Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.41 |
| ▸ | TSPO | P30536 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | RAC2 | P15153 | 1/20 | 0.36 |
| ▸ | RAC3 | P60763 | 1/20 | 0.36 |
| ▸ | CDC42 | P60953 | 1/20 | 0.36 |
| ▸ | RAC1 | P63000 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25937133 | 0.97 | L3MBTL1 (0.47) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL13724932 | 0.97 | KDM4E (0.44) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL25630825 | 0.97 | KDM4E (0.44) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL13725885 | 0.97 | KDM4E (0.42) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL15179757 | 0.96 | KDM4E (0.41) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL8928046 | 0.96 | KDM4E (0.49) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL13725850 | 0.96 | KDM4E (0.49) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL27465271 | 0.96 | KDM4E (0.49) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL8928125 | 0.96 | KDM4E (0.49) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL13725322 | 0.95 | TSPO (0.40) | KDM4EATML3MBTL1AKR1C4AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394511-B2 | Compound for forming organic film, and organic light emitting device and flat panel display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8394511-B2 | Compound for forming organic film, and organic light emitting device and flat panel display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-08-13 | — | — | US | disclosed |
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SLCO4C1, PORCN, SLC7A5 | KDM4E 2323/4885ATM 2834/4885L3MBTL1 1723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.